Skip to Content

Bryhali Approval Status

FDA Approved: No (Pending Approval)
Brand name: Bryhali
Generic name: halobetasol propionate
Dosage form: Lotion
Previous Name: Jemdel
Company: Ortho Dermatologics
Treatment for: Plaque Psoriasis

Bryhali (halobetasol propionate) is a high-potency topical steroid formulation in development for the treatment of plaque psoriasis.

Development Status and FDA Approval Process for Bryhali

Oct  9, 2018Bausch Health's Bryhali (halobetasol propionate) Lotion, 0.01%, Receives Tentative FDA Approval For Plaque Psoriasis In Adults
Feb 14, 2018Ortho Dermatologics Announces U.S. FDA Filing Acceptance for Jemdel Plaque Psoriasis Treatment

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.